Legend Biotech (LEGN) Other Non Operating Income (2020 - 2025)

Legend Biotech (LEGN) has 6 years of Other Non Operating Income data on file, last reported at -$2.4 million in Q4 2025.

• In Q4 2025, Other Non Operating Income fell 102.15% year-over-year to -$2.4 million; the TTM figure through Dec 2025 stood at -$164.7 million (down 1354.91% YoY), while the FY2025 annual figure was -$164.8 million, down 247.41% from the prior year.
• Other Non Operating Income fell to -$2.4 million in Q4 2025, from $354000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $111.4 million in Q4 2024 and bottomed at -$108.1 million in Q2 2025.
• A 5-year average of -$4.7 million and a median of $924000.0 in 2022 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2021 — Other Non Operating Income surged 7474.24% — and 2023, when it slumped 5919.13%.
• Year by year, Other Non Operating Income stood at $4.9 million in 2021, then surged by 88.19% to $9.2 million in 2022, then jumped by 318.52% to $38.3 million in 2023, then surged by 190.62% to $111.4 million in 2024, then sank by 102.15% to -$2.4 million in 2025.
• The last three Other Non Operating Income figures came in at -$2.4 million (Q4 2025), $354000.0 (Q3 2025), and -$108.1 million (Q2 2025), per Business Quant data.

Peer Comparison